Singapore markets close in 1 hour 27 minutes

Cue Health Inc. (HLTH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.86-0.29 (-3.17%)
At close: 04:00PM EST
8.84 -0.02 (-0.23%)
After hours: 05:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous close9.15
Bid0.00 x 1100
Ask0.00 x 800
Day's range8.72 - 9.60
52-week range8.53 - 22.55
Avg. volume775,388
Market cap1.297B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.51
Earnings date10 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est15.50
  • Business Wire

    Cue Health Reports Preliminary Fourth Quarter and Full Year 2021 Revenue

    SAN DIEGO, January 11, 2022--Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company, ("Cue’) today reported preliminary unaudited revenue for fourth quarter and full year 2021.

  • Business Wire

    Cue Health to Present at the 40th Annual J.P. Morgan Healthcare Conference

    SAN DIEGO, January 05, 2022--Cue Health ("Cue") (Nasdaq:HLTH), a healthcare technology company, announced today that its management team will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 5:15 p.m. Eastern Time.

  • Motley Fool

    Why Cue Health Blasted Higher Today

    Monday was a very good day for stocks in general, but it was a standout day for healthcare diagnostics specialist Cue Health (NASDAQ: HLTH). On its website, Cue Health isn't shy to point out that it's the maker of the first molecular diagnostic test for COVID-19 approved by the U.S. Food and Drug Administration (FDA). Cue Health's COVID diagnostic test is also a product that can be administered at home with no training.